MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: A pooled-analysis from the M-SKIP project

International Journal of Cancer

Volumn 136, Issue 3, 2015, Pages 618-631

  Pasquali, Elena ^a   García Borrón, José C ^b   Fargnoli, Maria Concetta ^c   Gandini, Sara ^a   Maisonneuve, Patrick ^a   Bagnardi, Vincenzo ^a,d   Specchia, Claudia ^e   Liu, Fan ^f   Kayser, Manfred ^f   Nijsten, Tamar ^f   Nagore, Eduardo ^g,h   Kumar, Rajiv ⁱ   Hansson, Johan ^j   Kanetsky, Peter A ^k   Ghiorzo, Paola ^l,m   Debniak, Tadeusz ⁿ   Branicki, Wojciech ^o   Gruis, Nelleke A ^p   Han, Jiali ^q,r   Dwyer, Terry ^s   Blizzard, Leigh ^t   Landi, Maria Teresa ^u   Palmieri, Giuseppe ^v   Ribas, Gloria ^w   Stratigos, Alexander ^x   Council, M Laurin ^y   Autier, Philippe ^z   Little, Julian ^aa   Newton Bishop, Julia ^ab   Sera, Francesco ^ac   Raimondi, Sara ^a   Caini, Saverio ^ad   Hofman, Albert ^f   Uitterlinden, Andre G ^f   Scherer, Dominique ⁱ   Hoiom, Veronica ^j   Pastorino, Lorenza ^l   Cochrane, Jennifer ^t   Fernandez De Misa, Ricardo ^ae   Morling, Niels ^af   Johansen, Peter ^af   Pfeiffer, Ruth ^u   Kypreou, Katerina ^x   Bowcock, Anne ^y   Cornelius, Lynn ^y   Motokawa, Tomonori ^ag   Anno, Sumiko ^ah   Helsing, Per ^ai   Andresen, Per Arne ^ai   Wong, Terence H ^aj   more..

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MURCIA   (Spain)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^h UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j KAROLINSKA INSTITUTE   (Sweden)

^k H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^l UNIVERSITY OF GENOA   (Italy)

^m UNIVERSITY OF GENOA   (Italy)

ⁿ POMERANIAN MEDICAL UNIVERSITY   (Poland)

^o INSTITUTE OF FORENSIC RESEARCH   (Poland)

^p LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^q BRIGHAM AND WOMEN S HOSPITAL   (United States)

^r HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^s MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^t UNIVERSITY OF TASMANIA   (Australia)

^u NATIONAL CANCER INSTITUTE   (United States)

^v CNR   (Italy)

^w Instituto Universitario IVI INCLIVA   (Spain)

^x UNIVERSITY OF ATHENS   (Greece)

^y WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^z INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^aa UNIVERSITY OF OTTAWA   (Canada)

^ab UNIVERSITY OF LEEDS   (United Kingdom)

^ac UNIVERSITY COLLEGE LONDON   (United Kingdom)

^ad ISPO   (Italy)

^ae HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^af UNIVERSITY OF COPENHAGEN   (Denmark)

^ag POLA CHEMICAL INDUSTRIES INC   (Japan)

^ah SHIBAURA INSTITUTE OF TECHNOLOGY   (Japan)

^ai OSLO UNIVERSITY HOSPITAL   (Norway)

^aj UNIVERSITY OF EDINBURGH   (United Kingdom)

more..

Author keywords

Genetic epidemiology; Melanocortin 1 receptor; Melanoma; Meta analysis

Indexed keywords

MELANOCORTIN 1 RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAIR COLOR; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LENTIGO; MAJOR CLINICAL STUDY; MALE; MC1R GENE; MELANOMA SKIN CANCER; MIDDLE AGED; PHENOTYPE; SEQUENCE ANALYSIS; SKIN COLOR; GENETIC PREDISPOSITION; GENETICS; MELANOMA; RISK; SKIN NEOPLASMS; SKIN PIGMENTATION;

EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MELANOMA; MIDDLE AGED; PHENOTYPE; RECEPTOR, MELANOCORTIN, TYPE 1; RISK; SKIN NEOPLASMS; SKIN PIGMENTATION;

EID: 84911006044     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29018     Document Type: Article

References (50)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer, 2010. http://globocan.iarc.fr.
2. Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. Lancet 2005;365:687-701.
3. Gandini S, Sera F, Cattaruzza MS, et al. Metaanalysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005;41:2040-59.
4. Gandini S, Sera F, Cattaruzza MS, et al. Metaanalysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005;41:45-60.
5. Gandini S, Sera F, Cattaruzza MS, et al. Metaanalysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005;41:28-44.
6. Hayward NK. Genetics of melanoma predisposition. Oncogene 2003;22:3053-62.
7. Duffy DL, Box NF, Chen W, et al. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 2004;13:447-61.
8. Burchill SA, Ito S, Thody AJ. Effects of melanocyte-stimulating hormone on tyrosinase expression and melanin synthesis in hair follicular melanocytes of the mouse. J Endocrinol 1993; 137:189-95.
9. Rouzaud F, Kadekaro AL, Abdel-Malek ZA, et al. MC1R and the response of melanocytes to ultraviolet radiation. Mutat Res 2005;571:133-52.
10. Gerstenblith MR, Goldstein AM, Fargnoli MC, et al. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 2007;28:495-505.
11. Beaumont KA, Shekar SN, Newton RA, et al. Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum Mol Genet 2007;16:2249-60.
12. Beaumont KA, Shekar SN, Cook AL, et al. Red hair is the null phenotype of MC1R. Hum Mutat 2008;29:E88-94.
13. Doyle JR, Fortin JP, Beinborn M, et al. Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways. J Pharmacol Exp Ther 2012;342:318-26.
14. Raimondi S, Sera F, Gandini S, et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 2008;122: 2753-60.
15. Kanetsky PA, Panossian S, Elder DE, et al. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? Cancer 2010; 116:2416-28.
16. Chatzinasiou F, Lill CM, Kypreou K, et al. Comprehensive field synopsis and systematic metaanalyses of genetic association studies in cutaneous melanoma. J Natl Cancer Inst 2011;103:1227-35.
17. Amos CI, Wang LE, Lee JE, et al. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet 2011;20:5012-23.
18. Williams PF, Olsen CM, Hayward NK, et al. Melanocortin 1 receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden. Int J Cancer 2011;129:1730-40.
19. Kadekaro AL, Chen J, Yang J, et al. Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signaling pathway in human melanocytes. Mol Cancer Res 2012;10: 778-86.
20. Mitra D, Luo X, Morgan A, et al. An ultravioletradiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature 2012;491:449-53.
21. Raimondi S, Gandini S, Fargnoli MC, et al. Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies. BMC Med Res Methodol 2012; 12:116.
22. Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001; 117:294-300.
23. Dwyer T, Stankovich JM, Blizzard L, et al. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? Am J Epidemiol 2004;159:826-33.
24. Landi MT, Kanetsky PA, Tsang S, et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 2005;97:998-1007.
25. Debniak T, Scott R, Masojc B, et al. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer 2006;119:2597-602.
26. Fargnoli MC, Altobelli E, Keller G, et al. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study. Melanoma Res 2006;16:175-82.
27. Stratigos AJ, Dimisianos G, Nikolaou V, et al. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J Invest Dermatol 2006;126:1842-9.
28. Fernandez L, Milne R, Bravo J, et al. MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population. Carcinogenesis 2007;28; 1659-64.
29. Brudnik U, Branicki W, Wojas-Pelc A, et al. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population. Exp Dermatol 2009;18:167-74.
30. Casula M, Muggiano A, Cossu A, et al. Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy. BMC Cancer 2009;9:352.
31. Council ML, Gardner JM, Helms C, et al. Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients. Exp Dermatol 2006;18:485-7.
32. Nan H, Kraft P, Hunter DJ, et al. Genetic variants in pigmentation genes, pigmentary pheno-types, and risk of skin cancer in Caucasians. Int J Cancer 2009;125:909-17.
33. Hoiom V, Tuominen R, Kaller M, et al. MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters. Pigment Cell Melanoma Res 2009;22: 196-204.
34. Liu F, van Duijn K, Vingerling JR, et al. Eye color and the prediction of complex phenotypes from genotypes. Curr Biol 2009;19:R192-3.
35. Scherer D, Nagore E, Bermejo JL, et al. Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations. Int J Cancer 2009;125:1868-75.
36. Ghiorzo P, Bonelli L, Pastorino L, et al. MC1R variation and melanoma risk in relation to host/ clinical and environmental factors in CDKN2A positive and negative melanoma patients. Exp Dermatol 2012;21:718-20.
37. Davies JR, Randerson-Moor J, Kukalizch K, et al. Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study. Pigment Cell Melanoma Res 2012;25:384-94.
38. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 2002;21: 589-624.
39. Levy C, Khaled M, Fisher DE. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 2006;12:406-14.
40. D'Orazio JA, Nobuhisa T, Cui R, et al. Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature 2006;443:340-4.
41. Smalley K, Eisen T. The involvement of p38 mitogen-activated protein kinase in the alphamelanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells. FEBS Lett 2000; 476:198-202.
42. Herraiz C, Journe F, Abdel-Malek Z, et al. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. Mol Endocrinol 2006;25:138-56.
43. Herraiz C, Sanchez-Laorden BL, Jimenez-Cervantes C, et al. N-glycosylation of the human melanocortin 1 receptor: occupancy of glycosylation sequons and functional role. Pigment Cell Melanoma Res 2011;24:479-89.
44. Herraiz C, Journe F, Ghanem G, et al. Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells. Int J Biochem Cell Biol 2012;44:2244-52.
45. Nakayama K, Soemantri A, Jin F, et al. Identification of novel functional variants of the melanocortin 1 receptor gene originated from Asians. Hum Genet 2006;119:322-30.
46. Ibarrola-Villava M, Hu HH, Guedj M, et al. MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis. Eur J Cancer 2012;48:2183-91.
47. April CS, Barsh GS. Distinct pigmentary and melanocortin 1 receptor-dependent components of cutaneous defense against ultraviolet radiation. PLoS Genet 2007;3:e9.
48. Hauser JE, Kadekaro AL, Kavanagh RJ, et al. Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes. Pigment Cell Res 2006; 19:303-14.
49. Wong SS, Ainger SA, Leonard JH, et al. MC1R variant allele effects on UVR-induced phosphorylation of p38, p53, and DDB2 repair protein responses in melanocytic cells in culture. J Invest Dermatol 2012;132:1452-61.
50. Wikberg JE, Muceniece R, Mandrika I, et al. New aspects on the melanocortins and their receptors. Pharmacol Res 2000;42:393-420.